ADC Summit 2015
Date: | 18-May-15 to 19-May-15 |
Location: | Holiday Inn Bloomsbury / London / United Kingdom |
Category: | Healthcare & Pharmaceuticals Conferences & Trade Fairs |
Recent clinical successes have generated intense interest in antibody-drug conjugates and they are now an increasingly active area of biopharma research, with developers and manufacturers investing towards this revolutionary therapeutic. To develop ADCs that are more specific, more stable, and more effective; continued optimisation of the antibody, linker and payload of an ADC is critical.
SMi is delighted to announce that its 4th annual ADC Summit 2015 conference will take place on 18th - 19th May in London, UK.
This conference goes to the heart of the technological challenges and asks:
What does it take to develop superior ADCs and gain the clinical edge?
Join us as we share, confer and debate how to create the next wave of ADCs with better efficacy, lower toxicity and improved potency for clinical success.
REASONS TO ATTEND: ADC Summit 2015
- Hear more about the payload developments
- Receive updates on ADCs in clinical trials
- Learn more about biodistribution and tumour penetrations
- Aim for improvement of the therapeutic index
- Discover strategies for effective targeting ADC off-target toxicities
- Understand the status of the development of novel binding moieties
EXPERT SPEAKERS INCLUDE:
- Mahendra Deonarain, Chief Scientific Officer, Antikor Biopharma Ltd.
- David Thurston, Professor of Drug Discovery, King's College London
- Angela Romanelli, Senior Director, Biomarkers, ImmunoGen, Inc.
- Christophe Bonny, Chief Scientific Officer, Bicycle Therapeutics Limited
- Klaus Bosslet, Head Discovery Oncology, Pharma Research & Early Development, Roche Innovation Center Penzberg
- Iontcho Vlahov, Vice President of Discovery Chemistry, Endocyte, Inc.
- Vijay Chudasama, Research Associate, University College London
SMi is delighted to announce that its 4th annual ADC Summit 2015 conference will take place on 18th - 19th May in London, UK.
This conference goes to the heart of the technological challenges and asks:
What does it take to develop superior ADCs and gain the clinical edge?
Join us as we share, confer and debate how to create the next wave of ADCs with better efficacy, lower toxicity and improved potency for clinical success.
REASONS TO ATTEND: ADC Summit 2015
- Hear more about the payload developments
- Receive updates on ADCs in clinical trials
- Learn more about biodistribution and tumour penetrations
- Aim for improvement of the therapeutic index
- Discover strategies for effective targeting ADC off-target toxicities
- Understand the status of the development of novel binding moieties
EXPERT SPEAKERS INCLUDE:
- Mahendra Deonarain, Chief Scientific Officer, Antikor Biopharma Ltd.
- David Thurston, Professor of Drug Discovery, King's College London
- Angela Romanelli, Senior Director, Biomarkers, ImmunoGen, Inc.
- Christophe Bonny, Chief Scientific Officer, Bicycle Therapeutics Limited
- Klaus Bosslet, Head Discovery Oncology, Pharma Research & Early Development, Roche Innovation Center Penzberg
- Iontcho Vlahov, Vice President of Discovery Chemistry, Endocyte, Inc.
- Vijay Chudasama, Research Associate, University College London
EIN News
provides powerful, real-time media monitoring, news aggregation & syndication services. Read the latest news about this topic. See:
- Autism News Today
- Brain Cancer News Today
- Breast Cancer News Today
- Breastfeeding News Today
- Conferences & Trade Shows Today
- Dental Industry Today
- Dietary Supplements News Today
- H1N1 News Today
- H7N9 Bird Flu News Today
- Health Insurance Exchanges News
- Healthcare Industry Today
- Healthcare Reform News Today
- Home Birth News Today
- Lung Cancer News Today
- MERS News Today
- Malaria News Today
- Marijuana News Today
- Mesothelioma News Today
- Pharmaceutical Industry Today
- Planned Parenthood News Today
- Prostate Cancer News Today
- SARS News Today
- Wellness News Today